Iron Deficiency- New Evidence and Approaches

Activity Details
  • Credit Amounts:
    • CNE: 1.20
    • UNTHSC: 1.00
    • Physicians: 1.00
  • Cost: Free
  • Release: Aug 23, 2017
  • Expires: Aug 23, 2019
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Timothy  McCavit Timothy McCavit, MD
Hematology/Oncology Pediatrician
Cook Children's Medical Center
Fort Worth, Texas

Needs Statement

Iron deficiency anemia (IDA) is the most common cause of anemia in humans.  In spite of the frequency with which it is encountered in clinical practice, patients are often faced with clinicians who are uncertain about the diagnosis and treatment of IDA. This presentation will define IDA, briefly review the physiology of iron in humans, differentiate between IDA and other microcytic anemias in children, report the results of the recently-completed BESTIRON clinical trial, and discuss the use of parenteral iron for children with iron deficiency anemia. 

Target Audience

This activity was planned to address the educational needs of physicians, physician assistants, nurse practitioners and nurses

Objectives

  • Detail the common causes of iron deficiency anemia in children
  • Distinguish between iron deficiency anemia and thalassemia trait
  • Discuss new evidence regarding oral iron treatment in children
  • Describe the indications and new options for parenteral iron therapy in children

Accreditation

CNE

UNT Health Science Center is approved by the California Board of Registered Nursing, Provider # 16274. This activity is approved for 1.20 Contact Hours.

UNTHSC
The University of North Texas Health Science Center certifies this activity for 1.00 hour of participation.

Physicians

The University of North Texas Health Science Center is accredited by the American Osteopathic Association to award continuing medical education to physicians.

The University of North Texas Health Science Center has requested that the AOA Council on Continuing Medical Education approve this program for 1.00 hour of AOA Category 2B CME credits. Approval is currently pending.

The University of North Texas Health Science Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of North Texas Health Science Center designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of North Texas Health Science Center presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies

  • Medical knowledge

IOM Competencies

  • Employ evidence-based practice

Faculty Disclosure

Timothy McCavit, MD discloses he serves on the speaker's bureau for Novartis and Shire. The UNT Health Science Center Professional and Continuing Education staff have nothing to disclose.

Dr. McCavit will discuss the off-label use of ferric carboyxmaltose and other forms of parenteral iron which are not indicated in children.

Acknowledgment

Data collected as part of this activity may be analyzed as part of educational research to study the effectiveness of interventions. This project is included under UNTHSC IRB protocol #2017-056